|
![]() |
|
|
Phenylbutazone
drug data and news
Phenylbutazone drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.
|
| Generic name | Phenylbutazone | ||
| Brand Names/Synonyms | 'Esteve'; A 7514; Alindor; Alka Butazolidin; Alkabutazona; Alqoverin; Ambene; Anerval; Anpuzone; Antadol; Anuspiramin; Apo-Phenylbutazone; Arthrizon; Artizin; Artrizin; Artrizone; Artropan; Azdid; Azobutyl; Azolid; B.T.Z.; Benzone; Betazed; Bizolin; Bizolin 200; Bunetzone; Busone; Buta Phen; Butacompren; Butacote; Butadion; Butadiona; Butadione; Butagesic; Butalan; Butalgina; Butalidon; Butaluy; Butapirazol; Butapirazole; Butapyrazole; Butarecbon; Butartril; Butartrina; Butatron; Butazina; Butazolidin; Butazolidine; Butazona; Butazone; Bute; Butidiona; Butiwas-Simple; Butone; Butoz; Butylpyrin; Buvetzone; Buzon; Chembutazone; Cotylbutazone; DA-192; Digibutina; Diossidone; Diozol; Diphebuzol; Diphenylbutazone; Ecobutazone; Elmedal; Equi Bute; Equipalazone; Eributazone; Exrheudon N; Febuzina; Fenartil; Fenibutal; Fenibutasan; Fenibutazona; Fenibutol; Fenilbutazona; Fenilbutina; Fenilbutine; Fenilidina; Fenotone; Fenylbutazon; Flexazone; G 13, 871; Ia-But; Intalbut; Intrabutazone; Intrazone; Ipsoflame; Kadol; Lingel; Malgesic; Mepha-Butazon; Mephabutazon; Mephabutazone; Merizone; NCI-C55414; Nadazone; Nadozone; Neo-Zoline; Novophenyl; PBZ; Phebuzin; Phebuzine; Phenbutazol; Phenbutazone; Phenopyrine; Phenyl-Mobuzon; Phenylbutaz; Phenylbutazone; Phenylbutazonum; Phenyzene; Phenyzone; Pirarreumol &Quot;B&Quot;; Pirarreumol B; Praecirheumin; Pyrabutol; Pyrazolidin; Rectofasa; Reudo; Reudox; Reumasyl; Reumazin; Reumazol; Reumune; Reumuzol; Reupolar; Robizon-V; Robizone; Robizone-V; Rubatone; Scanbutazone; Schemergin; Shigrodin; Tazone; Tencodyne; Tetnor; Tevcodyne; Therazone; Ticinil; Todalgil; Usaf Ge-15; Uzone; VAC-10; Wescozone; Zolaphen; Zolidinum; Zorane | ||
| Indication | For the treatment of backache and ankylosing spondylitis | ||
| Sponsored links | Description | Not Available | |
| Pharmacology | Phenylbutazone is a synthetic, pyrazolone derivative. It is a nonhormonal anti-inflammatory, antipyretic compound useful in the management of inflammatory conditions. The apparent analgesic effect is probably related mainly to the compound's anti-inflammatory properties and arise from its ability to reduce production of prostaglandin H and prostacyclin. Prostaglandins act on a variety of cells such as vascular smooth muscle cells causing constriction or dilation, on platelets causing aggregation or disaggregation and on spinal neurons causing pain. Prostacylcin causes vascular constriction platelet disaggregation | ||
| Mechanism Of Action | Phenylbutazone binds to and inactivates prostaglandin H synthase and prostacyclin synthase through peroxide (H2O2) mediated deactivation. The reduced production of prostaglandin leads to reduced inflammation of the surrounding tissues. | ||
| Phenylbutazone News (When available) |
NSAIDs: Pain Relief or Pain in the Gut? May 2, 2006 Wound care for sales horses May 9, 2006 24 hours till 'go' time May 7, 2006 Rolex Talk Highlights Performance Horse Issues May 3, 2006 Kentucky Issues Advisory on Naproxen Use Apr 20, 2006 | ||
| Dosage Forms | BOLUS; LIQUID; PASTE; POWDER; SOLUTION; TABLET | ||
| Drug_Category | Anti-inflammatory Agents; Nonsteroidal Antiinflammatory Agents (NSAIDs); ATC:M01AA01; ATC:M02AA01 | ||
| Absorption | Not Available | ||
| Interactions | Not Available | ||
| Toxicity | Oral, LD50 = 238 mg/kg (mouse); Oral, LD50 = 781 mg/kg (rabbit); Oral, LD50 = 245 mg/kg (rat); Oral, LD50 = 375 mg/kg (rat) | ||
| Organisms Affected | Humans and other mammals | ||
| Chemical IUPAC Name | 4-butyl-1,2-diphenyl-pyrazolidine-3,5-dione | ||
| Chemical Formula | C19H20N2O2 | ||
| Molecular Weight | 308.374 g/mol | ||
| Smiles String | CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3 | ||
| Melting Point | 105 °C | ||
| Water Solubility | 47.5 mg/L | ||
| State | Solid | ||
| LogP/Hphobicity | 4.214 | ||
| Isoelectric Point | 4.5 | ||
| Biotransformation | Not Available | ||
| Half Life | Not Available | ||
| Protein Binding [%] | Not Available | ||
| RxList Link | Not Available>RXlist | ||
| Sponsored links | |||
| Drug Reference | http://www.drugs.com/cons/Phenylbutazone.html | ||
| Drug Type | Approved Drug | ||
| Accession No | APRD00409 | ||
| CAS Registry Number | 50-33-9 | ||
| KEGG Compound ID | C07440 | ||
| PubChem ID | SID:9644 | ||
| PharmGKB ID | PA450932 | ||
| SwissProt ID | Not Available | ||
| GenBank ID | Not Available | ||
| Drug ID Number [DIN] | 596701 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |